EMD Serono - About the company
EMD Serono is a deadpooled company based in Rockland (United States), founded in 2012. It operates as a Developer of immuno-oncology therapies for treating psoriasis, lupus, and multiple sclerosis. The company has 347 active competitors, including 129 funded and 80 that have exited. Its top competitors include companies like Abcellera Biologics, Agios Pharmaceuticals and TScan Therapeutics.
Company Details
EMD Serono is developing immuno-oncology therapies for treating psoriasis, lupus, and multiple sclerosis. The lead candidate of the company, avelumab, which is an anti-PD-L1 antibody used to treat non-small cell lung cancer. It also provides MAVENCLAD and Rebif drugs for neurological and immunological diseases.
- Website
- www.emdserono.com/us-en
- Social
- Email ID
- *****@emdserono.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2012
Location
Rockland, United States
Stage
Deadpooled
Ranked
77th among 347 active competitors
Employee Count
1,783 as on Apr 30, 2026
Similar Companies
Sign up to download EMD Serono's company profile
EMD Serono's funding and investors
EMD Serono has not raised any funding rounds yet.
EMD Serono's founders and board of directors
Founder? Claim ProfileEMD Serono's employee count trend
EMD Serono has 1,783 employees as of Apr 26. Here is EMD Serono's employee count trend over the years:
Uncover EMD Serono's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
EMD Serono's Competitors and alternates
Top competitors of EMD Serono include Abcellera Biologics, Agios Pharmaceuticals and TScan Therapeutics. Here is the list of Top 10 competitors of EMD Serono, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Abcellera Biologics 2012, Vancouver (Canada), Public | AI-enabled platform for antibodies discovery | $115M | 71/100 | |
2nd | Agios Pharmaceuticals 2008, Cambridge (United States), Public | Developer of therapeutics in the field of cancer metabolism and rare genetic disorders of metabolism | $120M | 70/100 | |
3rd | _1556184640480.png?devicePixelRatio=2&height=30&width=30){kind=logo} TScan Therapeutics 1995, Boston (United States), Public | Developer of T cell therapies to harness the immune system against cancer | $180M | 70/100 | |
4th | _1548143983431.png?devicePixelRatio=2&height=30&width=30){kind=logo} Beijing Jiakesi drug development 2015, Beijing (China), Public | Developer of small molecule based therapeutics for cancer treatment | $55M | 67/100 | |
5th | AnaptysBio 2005, San Diego (United States), Public | Developer of immunology therapeutics for cancer and inflammatory diseases | $85.7M | 67/100 | |
6th |  Alector 2013, San Francisco (United States), Public | Developing immuno-modulatory therapies for dementia and other neurodegenerative disorders | $215M | 65/100 | |
7th | Immuno-oncology company with propreitary in-silico drug discovery platform | $35.4M | 63/100 | ||
8th | Lyell Immunopharma 2018, San Francisco (United States), Public | Developer of CAR- T therapy for cancer treatment | $493M | 63/100 | |
9th | ABL Bio 2016, Seongnam-si (South Korea), Public | Bi-specific antibodies and Antibody-drug Conjugate immunotherapies for oncology and neurodegenerative diseases | $65M | 63/100 | |
10th | Cumulus Oncology 2017, Edinburgh (United Kingdom), Seed | Developer of therapies for treating cancers | $19.2M | 61/100 | |
77th | EMD Serono 2012, Rockland (United States), Deadpooled | Developer of immuno-oncology therapies for treating psoriasis, lupus, and multiple sclerosis | - | - | 46/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on EMD Serono's competitors? Click here to see the top ones
EMD Serono's Investments and acquisitions
EMD Serono has made no investments or acquisitions yet.
Reports related to EMD Serono
Here is the latest report on EMD Serono's sector:
News related to EMD Serono
Filter this listMedia has covered EMD Serono for a total of 6 events in the last 1 year, 3 of them have been about company updates.
•
EMD Serono Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients with Active Skin ManifestationsBusiness Wire•Jul 08, 2026•EMD Serono
•
EMD Serono Advances Patient Access to IVF Medicines in the U.S., Aligned with National Health PrioritiesBusiness Wire•Feb 06, 2026•EMD Serono
•
FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell TumorBusiness Wire•Jan 13, 2026•Merck, EMD Serono
•
EMD Serono Takes Patient-Directed Approach to Bring Innovation to the Treatment of Rare Neuromuscular Disorder, Generalized Myasthenia GravisBusiness Wire•Nov 24, 2025•EMD Serono
•
Donald Trump Announces IVF Drug Price Cuts and Employer Benefit PushThe West Australian•Oct 17, 2025•EMD Serono, Merck, CVS Health, AstraZeneca and 1 other
•
EMD Serono Announces Agreement with U.S. Government to Expand Access to IVF TherapiesBusiness Wire•Oct 17, 2025•EMD Serono
•
EMD Serono Announces Positive Phase 2 Data for Enpatoran in Lupus TreatmentFinancial Post•May 21, 2025•EMD Serono
•
Medisafe and EMD Serono Partner to Launch Global HIV Resource CenterHIT Consultant•Mar 05, 2025•Medisafe, EMD Serono
•
Emd Serono Appoints Miguel Fernández Alcalde to Lead North American Healthcare BusinessBusiness Wire•Dec 11, 2024•EMD Serono
•
Model N: The Leader in Revenue Optimisation and ComplianceHealthcare GL•May 02, 2024•Model N, EMD Serono
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about EMD Serono
Explore our recently published companies
- Persistent Petrochem - Mumbai based, 2022 founded, Unfunded company
- SoftTalk - Noida based, 2026 founded, Unfunded company
- Gravity Base - Dubai based, 2014 founded, Unfunded company
- Terablaz Media - Ahmedabad based, 2023 founded, Unfunded company
- Way2Max - Jaipur based, 2021 founded, Unfunded company
- IATrain - Picos based, 2024 founded, Unfunded company
